RxDoctor Payments Data

Heather Barnes, MD

Family Medicine · Yukon, OKNPI 1932326469

Payments from drug & device makers

$5,558in general payments, 2019–2025

Across 380 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$718
  • Pfizer$597
  • Lilly USA, LLC$494
  • GSK$491
  • Astellas Pharma US Inc$490
  • Novo Nordisk$408
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$5,37697%
  • Education$1833%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,558 in reported general payments places this provider in the 85th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$60,905
Medicare patients
130
Services billed
1,188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide173$204,019
OzempicSemaglutide45$42,514
JardianceEmpagliflozin28$27,124
TrulicityDulaglutide21$20,461
EliquisApixaban13$20,022
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$16,868
Soliqua 100-33Insulin Glargine/Lixisenatide13$9,632
Breo ElliptaFluticasone/Vilanterol22$9,329
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen191$5,444
Omeprazole141$3,007
Rosuvastatin Calcium257$2,736
Levothyroxine Sodium212$2,185
SynthroidLevothyroxine Sodium18$2,131
Gabapentin91$2,121
Pregabalin32$1,878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$494$224,481194 claims
Novo NordiskOzempic$408$42,51445 claims
Boehringer IngelheimJardiance$360$27,12428 claims
GSKTrelegy Ellipta, Breo Ellipta$491$26,19748 claims
PfizerEliquis$597$20,02213 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$151$9,63213 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$2,185212 claims
AbbVieSynthroid$718$2,13118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Yukon

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →